BMJ Open
March 2015
Introduction: Adults with end-stage kidney disease (ESKD) treated with haemodialysis experience mortality of between 15% and 20% each year. Effective interventions that improve health outcomes for long-term dialysis patients remain unproven. Novel and testable determinants of health in dialysis are needed.
View Article and Find Full Text PDFPurpose: The purpose of this study is to explore how vascular access care was reimbursed, promoted, and organised at the national level in European and neighbouring countries.
Methods: An electronic survey among national experts to collect country-level data.
Results: Forty-seven experts (response rate, 76%) from 37 countries participated.